Antares Pharma Stock Forecast NASDAQ:ATRS

Price Target and Analyst Ratings

Most Recent Rating

On August 06, 2021 "HC Wainwright" gave "$5.00 - $5.50" rating for ATRS. The price target was changed from $4.23 to 0.7%.

Last 30 Days

Historical Ratings

Date	Rating	Action	Authority	Current Price	Target Price
2021-08-06	$5.00 - $5.50	Target Raised by	HC Wainwright	$4.10	$4.23→0.7%
2021-07-16	$7.00	Initiated by	Truist Financial	$4.15	$4.22+2.4%
2021-07-16	$7.00	Initiated by	Truist Securities	$4.15	$4.12→3.5%
2021-07-16	$7.00	Initiated by	Truist	$4.15	$4.12→3.5%
2021-05-17	Buy	Target Raised by	HC Wainwright	$4.04	$4.50 → $5.00
2021-05-10	Buy	Target Raised by	HC Wainwright	$3.80	$4.50 → $5.00
2021-05-10	Buy	Reiterated by	HC Wainwright	$3.80	$5.00
2020-10-01	Buy	Reiterated by	Raymond James	$2.84
2020-09-15	Buy	Reiterated by	Raymond James	$2.75	$6.00
2020-08-24	Buy	Reiterated by	Raymond James	$2.61
2020-08-17	Buy	Reiterated by	Raymond James	$2.94
2020-08-10	Buy	Reiterated by	HC Wainwright	$3.06
2020-06-21	Overweight	Reiterated by	Piper Sandler	$2.90	$5.00
2020-06-21	Buy	Reiterated by	LADENBURG THALM/SH SH	$2.90	$7.00
2020-05-06	Buy	Target Lowered by	HC Wainwright	$2.71	$5.00 → $4.50

ATRS Stock Trend

The stock lies in the lower of a wide and falling trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $3.58 is broken, it will firstly indicate a stronger fall rate.

Given the current short-term trend, the stock is expected to fall -16.57% during the next 3 months and, with a 90% probability hold a price between $2.99 and $3.35 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

WARNING: Trend forecast is still in the development phase and should be used with caution. Some cases might produce unexpected results such as negative prices at the end of the trend.

Data

Date	Bottom	Mid	Top
2021-09-22	$3.57	$3.79	$4.01
2021-09-23	$3.56	$3.78	$3.99
2021-09-24	$3.55	$3.76	$3.98
2021-09-27	$3.53	$3.75	$3.97
2021-09-28	$3.52	$3.74	$3.96
2021-09-29	$3.51	$3.73	$3.94
2021-09-30	$3.50	$3.71	$3.93
2021-10-01	$3.48	$3.70	$3.92
2021-10-04	$3.47	$3.69	$3.91
2021-10-05	$3.46	$3.68	$3.89
2021-10-06	$3.45	$3.66	$3.88
2021-10-07	$3.43	$3.65	$3.87
2021-10-08	$3.42	$3.64	$3.85
2021-10-11	$3.41	$3.62	$3.84
2021-10-12	$3.39	$3.61	$3.83
2021-10-13	$3.38	$3.60	$3.82
2021-10-14	$3.37	$3.59	$3.80
2021-10-15	$3.36	$3.57	$3.79
2021-10-18	$3.34	$3.56	$3.78
2021-10-19	$3.33	$3.55	$3.77
2021-10-20	$3.32	$3.54	$3.75
2021-10-21	$3.31	$3.52	$3.74
2021-10-22	$3.29	$3.51	$3.73
2021-10-25	$3.28	$3.50	$3.71
2021-10-26	$3.27	$3.49	$3.70
2021-10-27	$3.26	$3.47	$3.69
2021-10-28	$3.24	$3.46	$3.68
2021-10-29	$3.23	$3.45	$3.66
2021-11-01	$3.22	$3.43	$3.65
2021-11-02	$3.20	$3.42	$3.64

About Antares Pharma

Antares Pharma, Inc., a specialty pharmaceutical company, focuses on developing and commercializing self-administered parenteral pharmaceutical products and technologies worldwide. The companys injection products include OTREXUP that comprises of pre-filled methotrexate syringe and VIBEX self-injection system to enable rheumatoid arthritis (RA) and psoriasis patients to self-inject methotrexate at home; ZOMA-Jet and Twin-Jector, a needle-free a... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!